Minnesota Medical Foundation   Report issue

Foundation Phase 1 Phase 2 Phase 3
Founded: Minneapolis MN United States (1939)

Organization Overview

First Clinical Trial
2004
NCT00274404
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now